Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
N/A
Synonyms :
chromous sulfate
Class :
Transition metal sulfates
Dosage forms and strengths Â
Supplement Â
The dose of Cr (VI) is 1 to 3 grams
The dose of Cr (VI) is 1 to 3 grams
Not indicatedÂ
Refer adult dosingÂ
It may enhance the risk of adverse effects when combined with inorganic compounds
It may enhance the risk of adverse effects when combined with inorganic compounds
It may enhance the risk of adverse effects when combined with inorganic compounds
It may enhance the risk of adverse effects when combined with inorganic compounds
abacavir leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
aceclofenac leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
acemetacin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
acetaminophen leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
acetylsalicylic acid leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
aclidinium leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
acrivastine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
acyclovir leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
alclofenac leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
aldesleukin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
allopurinol leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
almasilate leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
almotriptan leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
alogliptin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
alprazolam leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amantadine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
aminophenazone leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amitriptyline leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
ammonium chloride leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amoxicillin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amphetamine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amphotericin b leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
ampicillin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
amrinone leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
ancestim leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
antipyrine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
antrafenine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
apalutamide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
apremilast leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
arformoterol leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
arsenic trioxide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
atazanavir leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
atomoxetine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
auranofin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
azacitidine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
azathioprine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
azelaic acid leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bacitracin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
baclofen leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
balsalazide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
baricitinib leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benorilate leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benoxaprofen leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benserazide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benzatropine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benznidazole leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
benzydamine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bepotastine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bicisate leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bisoprolol leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bisoxatin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bleomycin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
brivaracetam leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bromazepam leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
budesonide leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bumadizone leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
bupropion leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
buspirone leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
butabarbital leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
canagliflozin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
carbidopa leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
carboplatin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
carmustine leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
carprofen leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefaclor leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefadroxil leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefalotin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefapirin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefazolin leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefdinir leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefditoren leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
Actions and Spectrum:Â
Action:Â
An essential nutrient, chromium aids in the metabolism of blood fats, insulin, and glucose. Numerous investigations have linked it to the enhancement of insulin signaling cascades.Â
Frequency not defined Â
HeadacheÂ
InsomniaÂ
RashÂ
Skin and eye irritationÂ
Skin allergyÂ
Stomach upsetÂ
Trouble breathingÂ
Black Box Warning:Â Â
None
Contraindication/Caution:Â Â
Allergy or Sensitivity: Individuals with known hypersensitivity or allergies to chromium or any of the components in chromous sulfate should avoid its use.Â
Renal Impairment: People with kidney problems or impaired renal function may have difficulty eliminating chromium from their bodies, potentially leading to chromium accumulation and toxicity. Therefore, caution is advised, and use should be under strict medical supervision, if used at all.Â
Liver Dysfunction: Chromium metabolism occurs primarily in the liver. Individuals with liver disease or impaired liver function might have difficulty metabolizing chromium, leading to potential toxicity.Â
Diabetes or Hypoglycemia: Chromium has been suggested to impact insulin sensitivity. Therefore, individuals with diabetes or hypoglycemia should use chromium supplements cautiously and under medical supervision, as it may affect blood sugar levels.Â
Pregnancy and Breastfeeding: There’s insufficient evidence on the safety of chromous sulfate during pregnancy or breastfeeding. Hence, it’s generally recommended to avoid its use during these periods unless specifically prescribed by a healthcare provider after a thorough risk-benefit assessment.Â
Pregnancy warnings:    Â
Pregnancy category: N/AÂ
Lactation: Excreted into human milk is unknownÂ
Pregnancy Categories:        Â
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.Â
Category B: There were a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.  Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.  Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category
Pharmacology:Â Â
Pharmacodynamics:Â Â
Insulin Sensitizing Effects: Chromium may improve insulin sensitivity and can be beneficial in conditions where insulin resistance is a concern, such as type 2 diabetes.Â
Supplementation: Chromium supplements are available in different forms. It is often marketed as aids for weight loss, muscle building, and managing blood sugar levels. However, the evidence supporting these claims needs to be more conclusive.Â
Pharmacokinetics:Â
AbsorptionÂ
Chromous sulfate may be absorbed through ingestion or inhalation. However, the extent of absorption can vary based on factors such as the form of the compound, individual differences, and the presence of other substances.Â
DistributionÂ
Once absorbed, chromium compounds may be distributed through the bloodstream. They may also accumulate primarily in the kidneys, liver, spleen, and bones. Distribution to various tissues and organs could occur depending on the chemical form and pathways in the body.Â
MetabolismÂ
Chromium metabolism can vary depending on the oxidation state of the chromium compound. chromium (III), which is the likely state of chromous sulfate in the body, is generally believed to have low absorbability and low toxicity. It is not readily metabolized or transformed into other forms in the body.Â
Excretion and EliminationÂ
The excretion of chromium occurs mainly through the kidneys into urine. Some elimination may also occur through bile in the feces. The elimination half-life of chromium in the body can be prolonged, and it can accumulate with chronic exposure.Â
Administration: Â
Before beginning any chromium or mineral supplementation regimen, it is essential to take advice from a healthcare professional. They can evaluate possible dangers or drug interactions and offer advice based on each patient’s unique health needs.Â
Patient information leafletÂ
Generic Name: chromous sulfateÂ
Why do we use chromous sulfate?Â
chromium, typically in the +3-oxidation state (chromium (III), is used in trace amounts by the human body for its role in metabolism, specifically in the metabolism of proteins, fats,Â
and carbohydrates. Supplemental chromium (III) is sometimes used to help people with type 2 diabetes with their glucose metabolism.Â